ResMed reported $8.21B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Ansell USD 3.33B 3.2M Dec/2025
Artivion USD 1.04B 29.85M Sep/2026
AtriCure USD 717.54M 40.89M Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Cochlear AUD 2.79B 31.3M Dec/2025
Cooper Companies USD 12.67B 191.1M Jun/2026
CSL USD 37.9B 1.5B Dec/2025
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Fisher Paykel Healthcare NZD 2.85B 222.3M Jun/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Haemonetics USD 2.41B 45.2M Sep/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Philips EUR 28.03B 1.33B Sep/2026
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
ResMed USD 8.21B 754.14M Sep/2026
Sigma Healthcare AUD 8.29B 6.91B Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Steris USD 10.71B 22.5M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026